An early combination treatment of metformin and saxagliptinin improves the management of type 2 diabetes

VernacularTitle:早期应用二甲双胍联合沙格列汀治疗改善2型糖尿病的管理
Author: Weiqing WANG
Publication Type:Journal Article
Keywords: Diabetes mellitus,type 2; Metformin; Saxagliptin; Fixed dose combination
From: Chinese Journal of Endocrinology and Metabolism 2016;32(4):346-348
CountryChina
Language:Chinese
Abstract: It has been shown that compared with metformin monotherapy, an early combination treatment of saxagliptin and metformin significantly improves glycemic control with no increase in adverse effects in type 2 diabetic patients. The efficacy and safety profiles of saxagliptin/metformin fixed dose combination products are similar to those of the two-drug combination therapy, with lower frequency of administration and better compliance. Therefore, we believe that this drug will bring benefits to more type 2 diabetic patients in China.